• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Imaging and Intervention

Ultrasound-accelerated thrombolysis may improve pulmonary embolism outcomes

byXiaofan PanandAaron Maxwell, MD
February 22, 2015
in Imaging and Intervention
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In patients with acute submassive pulmonary embolism (PE), ultrasound-accelerated catheter-directed thrombolysis (USAT) safely and effectively improved right ventricular (RV) dysfunction.

2. USAT treatment of acute submassive PE was associated with significantly decreased main pulmonary artery pressure and reduced overall occurrence of acute pulmonary hypertension.

Evidence Rating Level: 2 (Good)       

Study Rundown: Acute PE is a potentially life-threatening disease spanning a wide spectrum of outcomes and clinical presentations, ranging from mild shortness of breath to complete circulatory collapse. The main predictors of mortality include systemic arterial hypotension and imaging or biomarker evidence of RV dysfunction at the time of diagnosis. Patients who are hemodynamically unstable are at high risk of death from worsening RV failure and cardiogenic shock. For those at increased risk of death, prompt revascularization by systemic fibrinolysis improves RV dysfunction and may improve survival and recurrent PE. However, systemic thrombolysis is associated with high rates of bleeding complications and guidelines recommend against its routine use. In pursuit of safer treatment and management approaches among patients with PE, therapies associated with a lower risk of adverse events such as USAT are being explored. USAT combines conventional catheter-directed thrombolysis with ultrasound, inducing disaggregation and separation of un-cross-linked fibrin fibers, thus increasing thrombus permeability for thrombolytic drugs. The primary goal of the present study was to retrospectively analyze the safety and efficacy of USAT for submassive PE, defined as PE with evidence of RV dysfunction but without hemodynamic instability. The procedure was successfully completed in all subjects included in the study with minimal complications; all-cause mortality and 30-day readmission rates demonstrated that USAT was a safe method for subjects of this study. Furthermore, USAT was found to be efficacious in this sample, significantly decreasing the main pulmonary artery pressure and improving RV function with minimal complication. The main limitation of this study was its lack of continuing follow up of the subjects’ post-USAT, thus long-term mortality estimates following USAT could not be determined. Future, prospective, controlled trials are necessary before widespread adoption of this treatment method for patients with submassive PE.

Click to read the study in the Journal of Vascular and Interventional Radiology

Relevant Reading: Short-term mortality in acute pulmonary embolism: clot burden and signs of right heart dysfunction at CT pulmonary angiography

In-Depth [retrospective cohort]: This study included data gathered from 45 consecutive patients, all of whom exhibited RV dysfunction as confirmed by right ventricle-to-left ventricle (RV:LV) ratio, who underwent USAT for acute submassive PE with 100% success rate for completion of the procedure. Hemodynamic evaluations were performed immediately after USAT and RV dysfunction was determined using RV:LV ratio evaluation at 48–72 hours after USAT by computed tomography angiography and echocardiography. Adverse outcomes and complications were reported for at least 30 days in each subject. The main pulmonary artery pressure decreased significantly from 49.8 mmHg to 31.1 mmHg (p<0.0001). Moreover, RV dysfunction significantly improved after USAT with mean RV:LV ratios decreasing from 1.59 to 0.93 (p< 0.0001). All-cause mortality at 30 days was 0% in the cohort. Four minor and two major adverse events were recorded, all of which were temporary and without long-term sequelae. No readmissions occurred within the 30-day follow-up period.

RELATED REPORTS

Venous thromboembolism rates in hospitalized children continue to rise

Rivaroxaban prophylaxis improves clinical outcomes in high-risk patients hospitalized with COVID-19

The use of a diagnostic strategy with age-adjusted D-dimer thresholds was non-inferior in risk-stratifying for thromboembolic events in emergency department patients with suspected pulmonary embolism

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: pulmonary embolism
Previous Post

Improved shoulder dystocia management and outcomes after training

Next Post

Topical pimecrolimus use for atopic dermatitis not linked to malignancy

RelatedReports

siRNA against antithrombin alleviates symptoms of hemophilia [PreClinical]
Chronic Disease

Venous thromboembolism rates in hospitalized children continue to rise

February 14, 2022
Most anticoagulants for venous thromboembolism similarly effective
Hematology

Rivaroxaban prophylaxis improves clinical outcomes in high-risk patients hospitalized with COVID-19

January 18, 2022
Quick Take: Hospital volume and outcomes for acute pulmonary embolism
Emergency

The use of a diagnostic strategy with age-adjusted D-dimer thresholds was non-inferior in risk-stratifying for thromboembolic events in emergency department patients with suspected pulmonary embolism

December 10, 2021
Thrombophilia-associated stillbirth risk appears limited to factor V Leiden
Emergency

Utility of D-dimer testing and modified thresholds for ruling out pulmonary embolism in COVID-19 patients

October 13, 2021
Next Post
Topical pimecrolimus use for atopic dermatitis not linked to malignancy

Topical pimecrolimus use for atopic dermatitis not linked to malignancy

Testosterone and estrogen exert independent effects in the pathogenesis of male hypogonadism

Long-term androgen deprivation may improve survival in prostate cancer

Hand dishwashing linked to fewer allergies in children

Hand dishwashing linked to fewer allergies in children

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Intravenous fluid restriction does not improve septic shock outcomes
  • Intravenous vitamin C increases mortality and organ dysfunction in sepsis patients
  • Magnetic resonance based preoperative evaluation for perianal fistulas superior to traditional clinical method and improve surgical outcomes [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.